Celebrities & GLP-1
Retatrutide, Ozempic & celebrities: why Hollywood, TV and business are talking about these compounds
From Oprah to Elon Musk, many public figures have openly discussed modern GLP-1 therapies. Retatrutide is different: the compound is still in clinical research.
Background
Why everyone suddenly talks about GLP-1 weight-loss drugs
Many well-known figures from Hollywood, TV and business have openly discussed modern GLP-1-based weight-loss treatments like Ozempic, Wegovy and Mounjaro. Names like Oprah Winfrey, Elon Musk, Whoopi Goldberg and Amy Schumer show just how mainstream weight management, appetite control and metabolic therapy have become.
Ozempic use is no longer discussed only in the diabetes community — red carpets, talk shows and business interviews have pushed the GLP-1 effect into the mainstream.
Notable names
Celebrities who have publicly talked about Ozempic, Wegovy or Mounjaro
The list below is based on public statements, interviews and podcasts. It is explicitly not medical advice and does not indicate which treatment is right for any specific person.
Oprah Winfrey
Publicly discussed using a GLP-1 weight-loss medication in a TV special.
Elon Musk
Repeatedly credited Wegovy/Ozempic for his notable weight loss.
Whoopi Goldberg
Openly discussed Mounjaro on 'The View'.
Amy Schumer
Spoke in interviews about earlier experiences with Ozempic.
Chelsea Handler
Shared on podcasts that she was unknowingly prescribed Ozempic.
Sharon Osbourne
Discussed her GLP-1 therapy experience in interviews.
Reta and celebrities
And Retatrutide? — the important difference
With Retatrutide — also known as Reta peptide or LY3437943 — the picture is different: the compound is still in clinical research and not yet approved as a freely available medicine. That's why there are currently no credibly confirmed celebrity experiences with Retatrutide.
Any headlines claiming "Retatrutide celebrity results" or "Reta before/after Hollywood" should be treated with skepticism — most are clickbait without reliable sources.
Retatrutide is not a supplement and not a lifestyle peptide. It is an investigational medical compound being studied in Phase III trials.
Why it's already a hot topic
Why Reta is being discussed so intensely already
Even without celebrity testimonials, Retatrutide is already being discussed intensely. The reason is simple: Reta acts as a triple agonist on GLP-1, GIP and glucagon — while Ozempic (Semaglutide) only activates GLP-1.
In published trials, Retatrutide shows markedly higher average weight loss than Ozempic or Mounjaro. That is the main reason Reta is seen as the potentially stronger next generation.
Ozempic / Wegovy
GLP-1 — famous via celebrity stories, ~15% weight loss.
Mounjaro / Zepbound
GLP-1 + GIP (dual) — stronger than Ozempic, ~20% weight loss.
Retatrutide (Reta)
GLP-1 + GIP + glucagon (triple) — up to ~24% in trials.
Framing
What this means for your own decision
Celebrity experiences with Ozempic, Wegovy or Mounjaro are interesting — but they are not a substitute for a proper medical assessment. What works for Oprah, Elon Musk or Whoopi Goldberg is not automatically the right path for any given individual.
Anyone interested in Retatrutide, Ozempic or Mounjaro should take the reputable route: medical consultation, a serious clinic, and clear information about effect, side effects and approval status — rather than anonymous online offers under keywords like "buy Retatrutide" or "Reta peptide no prescription".
Personal consultation on Retatrutide
Free initial consultation with a specialised medical team – in English or German.